Clinical Investigational Agents Consisting of Recombinant DNA or Infectious Agents
This Health Care Systems policy details the requirements for all investigational gene therapy agents or infectious agents that will be introduced into human subjects as part of a research protocol.
About this Policy
Program: Institutional Biosafety Committee
Type: IBC Policies